Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Immunohistochemical Approach for the Diagnosis of a Liver Mass on Small Biopsy Specimens.

Choi WT, Ramachandran R, Kakar S.

Hum Pathol. 2017 Jan 10. pii: S0046-8177(17)30014-X. doi: 10.1016/j.humpath.2016.12.025. [Epub ahead of print]

PMID:
28087475
2.

Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.

Sugimori K, Numata K, Okada M, Nihonmatsu H, Takebayashi S, Maeda S, Nakano M, Tanaka K.

J Med Ultrason (2001). 2017 Jan;44(1):89-100. doi: 10.1007/s10396-016-0750-9.

PMID:
27771842
3.

The Diagnostic Role of SPINK1 in Differentiating Hepatocellular Carcinoma From Nonmalignant Lesions.

Holah NS, El-Azab DS, Aiad HA, Sweed DM.

Appl Immunohistochem Mol Morphol. 2016 Mar 29. [Epub ahead of print]

PMID:
27028242
4.

Latest developments in precancerous lesions of hepatocellular carcinoma.

Niu ZS, Niu XJ, Wang WH, Zhao J.

World J Gastroenterol. 2016 Mar 28;22(12):3305-14. doi: 10.3748/wjg.v22.i12.3305.

6.

[Pathology-based differential diagnosis of high-grade dysplastic nodule from well-differentiated small hepatocellular carcinoma].

Feng LH, Cong WM.

Zhonghua Gan Zang Bing Za Zhi. 2015 Nov;23(11):870-3. doi: 10.3760/cma.j.issn.1007-3418.2015.11.015. Chinese. No abstract available.

PMID:
26743251
7.

Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications.

Sciarra A, Di Tommaso L, Nakano M, Destro A, Torzilli G, Donadon M, Maggioni M, Bosari S, Bulfamante G, Matsuda M, Fujii H, Ichikawa T, Morisaka H, Sano K, Ichikawa S, Roncalli M.

J Hepatol. 2016 Jan;64(1):87-93. doi: 10.1016/j.jhep.2015.08.031.

PMID:
26343958
8.

Gadoxetate Disodium-Enhanced MRI to Differentiate Dysplastic Nodules and Grade of Hepatocellular Carcinoma: Correlation With Histopathology.

Channual S, Tan N, Siripongsakun S, Lassman C, Lu DS, Raman SS.

AJR Am J Roentgenol. 2015 Sep;205(3):546-53. doi: 10.2214/AJR.14.12716.

PMID:
26295640
9.
10.

Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.

Numata K, Fukuda H, Nihonmatsu H, Kondo M, Nozaki A, Chuma M, Morimoto M, Oshima T, Okada M, Murakami T, Takebayashi S, Maeda S, Inayama Y, Nakano M, Tanaka K.

Abdom Imaging. 2015 Oct;40(7):2372-83. doi: 10.1007/s00261-015-0489-6.

PMID:
26099473
11.

Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.

Merkle EM, Zech CJ, Bartolozzi C, Bashir MR, Ba-Ssalamah A, Huppertz A, Lee JM, Ricke J, Sakamoto M, Sirlin CB, Ye SL, Zeng M.

Eur Radiol. 2016 Mar;26(3):674-82. doi: 10.1007/s00330-015-3873-2.

12.

[Dysplastic nodule of liver versus early hepatocellular carcinoma: a clinicopathologic and prognostic study].

Chen L, Tan Y, Zeng H, Hou Y, Xu J, Zhao J, Ji Y.

Zhonghua Bing Li Xue Za Zhi. 2014 May;43(5):301-6. Chinese.

PMID:
25030861
13.
14.

[Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].

Zhang Q, Ma Z, Xin Q, Liu GQ, Liu BB, Gao YT, Zhang CS, Du Z.

Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):924-8. doi: 10.3760/cma.j.issn.1007-3418.2013.12.010. Chinese.

PMID:
24636295
15.

Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis.

Iavarone M, Manini MA, Sangiovanni A, Fraquelli M, Forzenigo LV, Di Tommaso L, Aghemo A, Roncalli M, Ronchi G, Colombo M.

Dig Liver Dis. 2013 Jan;45(1):43-9. doi: 10.1016/j.dld.2012.08.009.

PMID:
23022425
16.

Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.

Bae JS, Noh SJ, Jang KY, Park HS, Chung MJ, Park CK, Moon WS.

Int J Oncol. 2012 Dec;41(6):2150-8. doi: 10.3892/ijo.2012.1631.

PMID:
22993038
17.

Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging.

Sugimoto K, Moriyasu F, Shiraishi J, Saito K, Taira J, Saguchi T, Imai Y.

Eur Radiol. 2012 Jun;22(6):1205-13. doi: 10.1007/s00330-011-2372-3.

PMID:
22270142
18.

Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.

Shafizadeh N, Kakar S.

Adv Anat Pathol. 2011 Nov;18(6):438-45. doi: 10.1097/PAP.0b013e318234abb4. Review.

PMID:
21993269
19.

Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule.

Saito K, Moriyasu F, Sugimoto K, Nishio R, Saguchi T, Nagao T, Taira J, Akata S, Tokuuye K.

World J Gastroenterol. 2011 Aug 14;17(30):3503-9. doi: 10.3748/wjg.v17.i30.3503.

20.

Using loss of heterozygosity of microsatellites to distinguish high-grade dysplastic nodule from early minute hepatocellular carcinoma.

Dong H, Cong WM, Xian ZH, Zhu ZZ.

Exp Mol Pathol. 2011 Oct;91(2):578-83. doi: 10.1016/j.yexmp.2011.06.003.

PMID:
21777579
Items per page

Supplemental Content

Loading ...
Support Center